You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMN107

Showing 26 - 50 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Leukemia, Myelogenous, Chronic Trial in Houston (Nilotinib)

Completed
Has Results
  • Leukemia, Myelogenous, Chronic
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 16, 2019

Untreated Adult Acute Myeloid Leukemia Trial in Scottsdale, Rochester (Cytarabine, Daunorubicin Hydrochloride, Laboratory

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +1 more
Aug 4, 2020

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

Completed
Has Results
  • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
  • Loma Linda, California
  • +35 more
Mar 25, 2021

Leukemia Trial in China (Imatinib, Nilotinib)

Completed
Has Results
  • Leukemia
  • Guangzhou, Guangdong, China
  • +11 more
Jul 11, 2019

Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib followed by treatment-free
  • Fort Myers, Florida
  • +113 more
Apr 25, 2022

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

Completed
  • Chronic Myeloid Leukemia
  • Ascoli Piceno, Italy
  • +21 more
Jan 3, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,

Completed
Has Results
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +9 more
  • Denver, Colorado
  • +2 more
Jan 17, 2020

Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)

Completed
Has Results
  • Mucosal Lentiginous Melanoma
  • +2 more
  • Santa Monica, California
  • +7 more
Oct 16, 2018

Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Leukemia Trial in Atlanta (Dasatinib, Imatinib Mesylate, Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Nov 1, 2018

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Minimal Residual Disease
  • Goodyear, Arizona
  • +237 more
Jan 3, 2023

Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
  • Linz, Oberoesterreich, Austria
  • +207 more
Jun 23, 2021

CML Trial in United States (nilotinib)

Completed
Has Results
  • CML
  • Birmingham, Alabama
  • +53 more
Feb 25, 2020

Myelogenous Leukemia, Chronic Trial in Worldwide (nilotinib, imatinib)

Completed
Has Results
  • Myelogenous Leukemia, Chronic
  • Los Angeles, California
  • +212 more
Oct 23, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Infant Mental Health, Parenting, Parent-Child Relations Trial in Copenhagen (VIPP-PUF)

Recruiting
  • Infant Mental Health
  • +2 more
  • VIPP-PUF
  • Copenhagen, Denmark
    National Institute of Public Health
Dec 7, 2022

Neurofibromatosis, NF1, Neurofibromas Trial in Indianapolis (Tasigna)

Completed
Has Results
  • Neurofibromatosis
  • +2 more
  • Indianapolis, Indiana
    Riley Hospital for Children
Apr 11, 2017

Leukemia, Myeloid, Chronic Trial in Israel (AMN107)

Completed
  • Leukemia, Myeloid, Chronic
  • AMN107
  • Haifa, Israel
  • +3 more
Mar 2, 2017

Gastrointestinal Stromal Tumors (GIST) Trial in Jerusalem, Tel Aviv, Tel Hashomer (AMN107- NILOTINIB)

Completed
  • Gastrointestinal Stromal Tumors (GIST)
  • AMN107- NILOTINIB
  • Jerusalem, Israel
  • +2 more
Jun 21, 2017

Gastrointestinal Stromal Tumors Trial in Japan (AMN107)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107
  • Nagoya, Aichi, Japan
  • +7 more
Feb 20, 2017

Philidelphia Positive Chronic Myeloid Leukaemia Trial in Australia (Nilotinib)

Terminated
Has Results
  • Philidelphia Positive Chronic Myeloid Leukaemia
  • Canberra, Australian Capital Territory, Australia
  • +13 more
Sep 26, 2017

Adrenomyeloneuropathy Trial in L'Hospitalet de LLobregat (N-acetylcysteine, lipoic acid, vitamin E)

Completed
  • Adrenomyeloneuropathy
  • L'Hospitalet de LLobregat, Barcelona, Spain
    Hospital Universitari de Bellvitge
Mar 7, 2019

Chronic Myelogenous Leukemia Trial in Gdansk, Poznan, Warsaw (nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Gdansk, Poland
  • +2 more
Nov 15, 2016

Chronic Myeloid Leukemia - Chronic Phase Trial in Doha (Dasatinib 100 MG [Sprycel], Nilotinib 150mg oral capsule [Tasigna])

Terminated
  • Chronic Myeloid Leukemia - Chronic Phase
  • Dasatinib 100 MG [Sprycel]
  • Nilotinib 150mg oral capsule [Tasigna]
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Jan 20, 2019